Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rabeprazole for GERD-Related Insomnia
NCT00287391Phase 4Completed
- Start
- Sep 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of rabeprazole in Insomnia and gastroesophageal reflux disease (GERD). Primary endpoint: Percentage of subjects with non-OSA sleep disturbances who demonstrate esophageal reflux, night-time arousals which are accompanied by a reflux event at 2 weeks. Started Sep 2004; status: completed.
02
Drugs
rabeprazole
03
Conditions
Insomniagastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT00287391.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00287391.